Valerie Beneke,Klaudia M Grieger,Christina Hartwig,Jan Müller,Kai Sohn,André-René Blaudszun,Nadja Hilger,Dirk Schaudien,Stephan Fricke,Armin Braun,Katherina Sewald,Christina Hesse
Valerie Beneke
Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Klaudia M Grieger
Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Christina Hartwig
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.
Jan Müller
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.
Center of Integrative Bioinformatics Vienna (CIBIV), Max Perutz Labs, University of Vienna and Medical University of Vienna, Vienna BioCenter, Vienna, Austria.
Member of the Vienna Biocenter PhD Program, University of Vienna and the Medical University of Vienna, Vienna, Austria.
Kai Sohn
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.
André-René Blaudszun
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Nadja Hilger
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Dirk Schaudien
Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Stephan Fricke
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Armin Braun
Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Institute for Immunology, Hannover Medical School, Hannover, Germany.
Katherina Sewald
Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
Christina Hesse
Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.
Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.
